Critical Review: Incannex Healthcare (NASDAQ:IXHL) & Aditxt (NASDAQ:ADTX)

Incannex Healthcare (NASDAQ:IXHL) and Aditxt (NASDAQ:ADTX) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, institutional ownership and valuation.

Insider & Institutional Ownership

0.4% of Incannex Healthcare shares are owned by institutional investors. Comparatively, 15.5% of Aditxt shares are owned by institutional investors. 9.1% of Incannex Healthcare shares are owned by company insiders. Comparatively, 0.0% of Aditxt shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Volatility and Risk

Incannex Healthcare has a beta of 7, indicating that its stock price is 600% more volatile than the S&P 500. Comparatively, Aditxt has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Incannex Healthcare and Aditxt, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Incannex Healthcare	2	0	1	0	1.67
Aditxt	1	0	0	0	1.00

Incannex Healthcare currently has a consensus target price of $18.00, indicating a potential upside of 802.26%. Given Incannex Healthcare’s stronger consensus rating and higher possible upside, equities analysts plainly believe Incannex Healthcare is more favorable than Aditxt.

Valuation & Earnings

This table compares Incannex Healthcare and Aditxt”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Incannex Healthcare	$90,000.00	278.19	-$19.30 million	($1.69)	-1.18
Aditxt	$14,336.00	0.02	-$41.71 million	($100,788.35)	-0.00

Incannex Healthcare has higher revenue and earnings than Aditxt. Incannex Healthcare is trading at a lower price-to-earnings ratio than Aditxt, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Incannex Healthcare and Aditxt’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Incannex Healthcare	N/A	-25.62%	-24.46%
Aditxt	-360,152.50%	-374.60%	-105.93%

Summary

Incannex Healthcare beats Aditxt on 12 of the 14 factors compared between the two stocks.

About Incannex Healthcare

Incannex Healthcare Limited (NASDAQ: IXHL) is an Australia-based clinical-stage pharmaceutical company developing cannabinoid- and psychedelic-assisted therapies for conditions with significant unmet medical needs. The company’s research programs are focused on areas including sleep disorders, pain, inflammation, mental health and traumatic brain injury. Incannex’s lead programs have included IHL-42X, an investigational combination therapy being developed for obstructive sleep apnea, and IHL-675A, a cannabinoid-based therapy studied for inflammatory conditions.

About Aditxt

Aditxt, Inc. (NASDAQ: ADTX) is a biotechnology company focused on developing technologies designed to monitor and improve the human immune system. Its work centers on immune profiling, precision health and personalized medicine, with the goal of helping healthcare providers and researchers better understand individual immune responses. The company’s primary technology platform, AditxtScore, is designed to analyze multiple immune system biomarkers simultaneously. The platform is intended for applications including disease detection, monitoring immune responses to infections and vaccines, and supporting the development of personalized treatment strategies.